Free Trial

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Receives Average Recommendation of "Moderate Buy" from Analysts

Acadia Healthcare logo with Medical background

Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Get Free Report) has been given an average recommendation of "Moderate Buy" by the nine brokerages that are covering the firm, Marketbeat.com reports. Three analysts have rated the stock with a hold rating and six have issued a buy rating on the company. The average twelve-month price objective among brokers that have updated their coverage on the stock in the last year is $47.94.

ACHC has been the topic of a number of research reports. Guggenheim started coverage on Acadia Healthcare in a report on Wednesday, April 9th. They issued a "buy" rating and a $36.00 price target on the stock. Bank of America cut their target price on shares of Acadia Healthcare from $50.00 to $44.50 and set a "buy" rating for the company in a research report on Friday, February 28th. KeyCorp lowered their price target on shares of Acadia Healthcare from $65.00 to $55.00 and set an "overweight" rating on the stock in a research report on Wednesday, May 14th. Barclays reduced their target price on Acadia Healthcare from $35.00 to $28.00 and set an "equal weight" rating on the stock in a research note on Wednesday, May 14th. Finally, Wall Street Zen upgraded Acadia Healthcare from a "sell" rating to a "hold" rating in a research report on Thursday, May 22nd.

Check Out Our Latest Stock Report on ACHC

Acadia Healthcare Stock Down 0.9%

Shares of Acadia Healthcare stock traded down $0.20 during trading on Monday, hitting $22.65. 69,976 shares of the stock were exchanged, compared to its average volume of 2,239,342. The firm's 50-day moving average price is $25.21 and its 200 day moving average price is $34.43. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.07 and a quick ratio of 1.07. The stock has a market cap of $2.09 billion, a price-to-earnings ratio of 7.42, a price-to-earnings-growth ratio of 1.46 and a beta of 1.01. Acadia Healthcare has a 12-month low of $20.36 and a 12-month high of $82.40.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last posted its quarterly earnings data on Monday, May 12th. The company reported $0.40 EPS for the quarter, beating analysts' consensus estimates of $0.35 by $0.05. The company had revenue of $770.51 million for the quarter, compared to analyst estimates of $769.90 million. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. Acadia Healthcare's quarterly revenue was up .3% on a year-over-year basis. During the same period in the previous year, the business posted $0.84 earnings per share. As a group, analysts forecast that Acadia Healthcare will post 3.38 earnings per share for the current fiscal year.

Institutional Trading of Acadia Healthcare

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. FMR LLC increased its holdings in Acadia Healthcare by 257.9% in the fourth quarter. FMR LLC now owns 6,230,631 shares of the company's stock valued at $247,045,000 after buying an additional 4,489,681 shares during the last quarter. Citigroup Inc. lifted its holdings in Acadia Healthcare by 5,144.2% in the first quarter. Citigroup Inc. now owns 2,376,209 shares of the company's stock worth $72,047,000 after acquiring an additional 2,330,898 shares during the last quarter. Hawk Ridge Capital Management LP boosted its stake in Acadia Healthcare by 437.5% in the first quarter. Hawk Ridge Capital Management LP now owns 2,473,226 shares of the company's stock valued at $74,988,000 after acquiring an additional 2,013,126 shares during the period. Madison Avenue Partners LP bought a new position in shares of Acadia Healthcare during the fourth quarter valued at approximately $76,339,000. Finally, Abrams Bison Investments LLC acquired a new stake in shares of Acadia Healthcare during the 1st quarter worth approximately $55,182,000.

About Acadia Healthcare

(Get Free Report

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.

Read More

Analyst Recommendations for Acadia Healthcare (NASDAQ:ACHC)

Should You Invest $1,000 in Acadia Healthcare Right Now?

Before you consider Acadia Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Acadia Healthcare wasn't on the list.

While Acadia Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Top 3 Defense Stocks to Profit From $175 Billion Golden Dome
Top 5 Stocks for June: AI Picks That Aren’t NVIDIA
This Unique Robotaxi Play Could Deliver 10X Returns

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines